Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance

By Lu Ellen   Wang Bing Wei   Guimond Colleen   Synnes Anne   Sadovnick A Dessa   Dahlgren Leanne   Traboulsee Anthony   Tremlett Helen  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 3, 2013-03 ,pp. : 251-261

Informa Healthcare

Access to resources Recommend Favorite

Nonclinical strategy considerations for safety pharmacology: evaluation of biopharmaceuticals

By Vargas Hugo M   Amouzadeh Hamid R   Engwall Michael J  

Expert Opinion on Drug Safety, Vol. 12, Iss. 1, 2013-01 ,pp. : 91-102

Informa Healthcare

Access to resources Recommend Favorite

Drugs with anticholinergic properties: a current perspective on use and safety

By Gerretsen Philip   Pollock Bruce G  

Expert Opinion on Drug Safety, Vol. 10, Iss. 5, 2011-09 ,pp. : 751-765

Informa Healthcare

Access to resources Recommend Favorite

Safety evaluation of the drugs available to prevent malaria

By Croft Ashley M   Cook Gordon C   Beer M Dominic   Whitehouse Dominic P  

Expert Opinion on Drug Safety, Vol. 1, Iss. 1, 2002-05 ,pp. : 19-27

Informa Healthcare

Access to resources Recommend Favorite

In Vitro Evaluation of Potential Hepatotoxicity Induced by Drugs

By  

Current Pharmaceutical Design, Vol. 16, Iss. 17, 2010-01 ,pp. : 1963-1977

Bentham Science Publishers

Access to resources Recommend Favorite